Nur Aliana Hidayah Mohamed is an academician and researcher in the field of biomedical sciences, specializing in medical pharmacology, drug delivery, and tissue engineering. She is currently a Senior Lecturer at the Faculty of Dentistry, Universiti Teknologi MARA (UiTM) Selangor Branch, and an Adjunct Associate Professor at the University of Puthisastra, Cambodia, for both the Faculty of Dentistry and the Faculty of Pharmacy. Her expertise spans multiple disciplines within the medical sciences.

Her academic journey began with a Bachelor of Biomedical Science from the Faculty of Medicine, University of Malaya, followed by a Master in Medical Science (MMedSc) from the Kulliyah of Medicine, International Islamic University Malaysia (IIUM), and a PhD in Drug Delivery and Tissue Regeneration from the University of Nottingham. Her educational background provides a strong foundation for her extensive research and teaching endeavours.

Her work focuses significantly on enhancing medical education and pioneering innovative research in drug delivery systems, bone scaffolds, and tissue engineering. Her teaching extends beyond Malaysia, having imparted knowledge in pharmacology, research design and methodology in countries such as Japan, Cambodia, China and Uzbekistan.

Her commitment to advancing medical science and technology ranges from drug delivery to tissue engineering. Current research includes the development of MicroX, a bone tissue grafting material, and contributions to bone tissue engineering through the use of drug-loaded PLGA microparticles, nanoparticles and the formation of 3D scaffolds.

As a member of prestigious societies such as the Society for Biomaterials, Tissue Engineering and Regenerative Medicine, the British Pharmacological Society and the European Cancer Association, she contributes not only to scientific advancements but also to medical education worldwide, specifically in the field of medical pharmacology. Her current research highlights the importance of 3D bioprinting in bone regeneration and engineering, particularly in the development of scaffolds for drug carriers and bioinks.

Her career is characterized by a continuous quest for knowledge, aiming not only to contribute to this innovative field but also to lead and pioneer breakthroughs that could one day redefine what is medically achievable. As the current head of the UiTM Microindustrial Hub (Tissue Engineering), she is furthering her efforts to partner with multiple industries and is working toward the commercialization of products in the near future.